AU1095595A - Gene therapy vector for the treatment of low or defective red blood cell production - Google Patents
Gene therapy vector for the treatment of low or defective red blood cell productionInfo
- Publication number
- AU1095595A AU1095595A AU10955/95A AU1095595A AU1095595A AU 1095595 A AU1095595 A AU 1095595A AU 10955/95 A AU10955/95 A AU 10955/95A AU 1095595 A AU1095595 A AU 1095595A AU 1095595 A AU1095595 A AU 1095595A
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- low
- red blood
- gene therapy
- blood cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14987193A | 1993-11-10 | 1993-11-10 | |
US149871 | 1993-11-10 | ||
US32048094A | 1994-10-07 | 1994-10-07 | |
US320480 | 1994-10-07 | ||
PCT/US1994/013066 WO1995013376A1 (en) | 1993-11-10 | 1994-11-09 | Gene therapy vector for the treatment of low or defective red blood cell production |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1095595A true AU1095595A (en) | 1995-05-29 |
Family
ID=26847119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU10955/95A Abandoned AU1095595A (en) | 1993-11-10 | 1994-11-09 | Gene therapy vector for the treatment of low or defective red blood cell production |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0737252A1 (en) |
AU (1) | AU1095595A (en) |
CA (1) | CA2183551A1 (en) |
WO (1) | WO1995013376A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9402857D0 (en) | 1994-02-15 | 1994-04-06 | Isis Innovation | Targeting gene therapy |
US6506379B1 (en) | 1995-06-07 | 2003-01-14 | Ariad Gene Therapeutics, Inc. | Intramuscular delivery of recombinant AAV |
US5962313A (en) | 1996-01-18 | 1999-10-05 | Avigen, Inc. | Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme |
US5846528A (en) * | 1996-01-18 | 1998-12-08 | Avigen, Inc. | Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence |
US5858351A (en) * | 1996-01-18 | 1999-01-12 | Avigen, Inc. | Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
DK0888385T3 (en) | 1996-03-14 | 2003-12-15 | Genentech Inc | GDNF receptor and uses thereof |
AU737129B2 (en) * | 1996-08-23 | 2001-08-09 | Arch Development Corporation | Long-term expression of gene products by transforming muscle cells |
US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
CA2360347C (en) | 1998-12-31 | 2013-05-07 | Chiron Corporation | Improved expression of hiv polypeptides and production of virus-like particles |
US6555343B1 (en) | 1999-05-07 | 2003-04-29 | Genentech Inc. | Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same |
WO2000068376A1 (en) * | 1999-05-07 | 2000-11-16 | Genentech, Inc. | Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
US6831060B2 (en) | 1999-05-07 | 2004-12-14 | Genentech, Inc. | Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same |
KR20030070702A (en) * | 2002-02-26 | 2003-09-02 | 사회복지법인삼성생명공익재단(삼성서울병원) | Method of electroporation-mediated dna delivery and its application to the expression of erythropoietin |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173067B1 (en) * | 1986-06-27 | 1999-12-13 | Univ Washington | Human erythropoietin gene, method of expression thereof in transfected cell lines, the transfected cell lines |
US5538722A (en) * | 1989-06-13 | 1996-07-23 | Stanford University | Isolation, growth, differentiation and genetic engineering of human muscle cells |
JPH08501210A (en) * | 1992-07-02 | 1996-02-13 | ザ ソールク インスチチュート フォア バイオロジカル スタディズ | Utilization of myoblasts for sustained release of gene products |
-
1994
- 1994-11-09 CA CA 2183551 patent/CA2183551A1/en not_active Abandoned
- 1994-11-09 WO PCT/US1994/013066 patent/WO1995013376A1/en not_active Application Discontinuation
- 1994-11-09 EP EP95901877A patent/EP0737252A1/en not_active Withdrawn
- 1994-11-09 AU AU10955/95A patent/AU1095595A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2183551A1 (en) | 1995-05-18 |
EP0737252A1 (en) | 1996-10-16 |
WO1995013376A1 (en) | 1995-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0686203A4 (en) | Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death | |
AU2552795A (en) | Safe vectors for gene therapy | |
AU1409488A (en) | Coagulation treatment of fluids | |
AU6194894A (en) | Bile acid derivatives, processes for their preparation and the use of these compounds as medicaments | |
EP0690673A4 (en) | Systemic gene treatment of connective tissue diseases | |
AU3972893A (en) | Gene therapy using the intestine | |
AU7867994A (en) | Hemofiltration of mediator-related diseases | |
AU699706C (en) | Improved vectors for gene therapy | |
AU2080988A (en) | Esters of 13-trans-retinoic acid | |
AU3022592A (en) | Hydrometallurgical process for the treatment of copper-bearing ore | |
AU8089494A (en) | Composition and method for treating blood vessel disorders of the skin using vitamin | |
AU4958096A (en) | Process for the treatment of gases | |
AU6797094A (en) | Cosmetic treatment of substrates | |
AU1095595A (en) | Gene therapy vector for the treatment of low or defective red blood cell production | |
AU6793594A (en) | Apparatus for the treatment of overbite | |
AU7816694A (en) | Method and system for the treatment of seeds and bulbs | |
AU3133889A (en) | Method for the treatment of the extraphyramidal side effects associated with neuroleptic therapy | |
AU1438295A (en) | Method for treatment of papulo-pustules and comedones of the skin | |
AU4859596A (en) | Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases | |
AU2403988A (en) | Processed red blood cells and process for producing the same | |
AU1118588A (en) | Process and equipment for the rapid determination of the spermium cell count and/or living spermium count | |
AU1867297A (en) | Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders | |
AU4805093A (en) | Methods for treatment of enzyme preparations | |
AU6336186A (en) | Process for treatment of allergies | |
AU4172089A (en) | Phosphonic acid containing cotelomers, and their use for water treatment |